Mycronic Grows Full-Year Sales 12% in 2025
STOCKHOM, SWEDEN – Mycronic reported record order intake and net sales for the full year ended in December, supported by AI-driven demand across semiconductor and PCB markets, while increased investment weighed on profitability late in the year.
For full-year 2025, order intake rose 2% to approximately $732 million, while net sales increased 12% to about $748 million.
Fourth-quarter results were softer. Order intake declined 19% to around $183 million, while net sales slipped 2% to approximately $191 million.
AI-related demand continued to support investments in semiconductor photomask, PCB test and die bonding equipment, while PCB assembly solutions faced a weaker European market. During the quarter, Mycronic inaugurated a new production facility in Thailand and continued expanding capacity to support long-term growth.
Following the reporting period, Mycronic completed the acquisition of Germany-based ETZ, a test probe manufacturer that will be integrated into the PCB Test business line. Looking ahead, the Board expects 2026 net sales to reach approximately $780 million.
